Cancer

Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance

SAN DIEGO and TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:…

9 months ago

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry…

9 months ago

Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific

EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test AccuracyMISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE…

9 months ago

4baseCare Secures CAP Accreditation, Elevating Genomic Profiling Standards for Cancer Patients in the UAE

BENGALURU, India , March 17, 2025 /PRNewswire/ -- 4baseCare, a leader in precision oncology, has achieved a major milestone with CAP…

9 months ago

Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

- The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα…

9 months ago

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients…

9 months ago

Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden

Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant…

10 months ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF”)…

10 months ago

Fuse Oncology, ACRO Partner to Integrate Clinical Pathways Platform

Strategic agreement will standardize clinical pathways through ACROPath® BOONE, N.C., March 13, 2025 /PRNewswire/ -- Fuse Oncology, an oncology healthcare software…

10 months ago

Base Molecular Resonance™ Technologies Introduces Game-Changing Solution to Stop Mass Livestock Culling Amid Bird Flu Crisis

BMRT's Revolutionary Technology Can Instantly Detect Infected Poultry, Preventing the Unnecessary Slaughter of Healthy Animals STUART, Fla., March 13, 2025 /PRNewswire/…

10 months ago